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Letter to the Editor 
A Psychometric Comparison of Two Carer 
Quality of Life Questionnaires in 
Huntington’s Disease: Implications for 
Neurodegenerative Disorders - A response to: 
Hagell and Smith (2013) Journal of 
Huntington’s Disease 2(3) 315-322 
A. Aubeeluck, H. Buchanan and E. Stupple 
Dear Editor, 
Hagell and Smith (H&S, [6]) present an analysis of 
the Huntington’s Disease Quality of Life Battery for 
Carers (HDQOL-C) to test and compare it with the 
Alzheimer’s Carers Quality of Life Inventory. They 
claim the HDQOL-C “fail[s] to meet basic psychome-
tric properties” (p. 315) and argue for “the feasibility 
of a common neurodegenerative carer QoL question-
naire” (p. 319). We feel their dismissal of the need for 
a scale that examines the unique disease-specific 
issues that HD carers face, is unjustified. We question 
their characterisation of the HDQoL-C, methodology 
and analyses, and argue that their dataset fails to meet 
basic psychometric criteria. 
A small sample (n = approximately 45 when 
accounting for missing data), from one clinic, in one 
geographical location is unlikely to be generalisable to 
the wider HD carer population. It is not surprising that 
the HDQoL-C subscales do not fare well when tested 
on such a homogenous data set, particularly as some 
items evaluate standards of support available in the 
carer’s location. Moreover, replication studies should 
match or exceed the sample size of previous work. 
Our previous data (1: n = 87; 2: n = 301), provide a far 
superior sample of carers from across the EU. Psycho-
metric evaluation usually includes factor analysis and 
standard tests of validity. H&S present under-powered 
and predominantly descriptive analyses from a data set 
that does not meet standard psychometric criteria. 
Therefore, H&S’s claim that the HDQoL-C is not 
psychometrically sound is difficult to justify. 
H&S challenge the HDQoL’s “suitability among HD 
carers” (p. 319), and “user friendliness” (p. 319) based 
on completion rates. In comparison studies, counter-
balancing of scale completion is essential, but was not 
reported by H&S. We have found better completion 
rates in our studies and would need convincing that 
there was more to these differences than random fluctu-
ation in their sample. Indeed, carers in our studies have 
reported that completing the HDQOL-C is a positive 
and therapeutic experience that offers opportunities for 
self-reflection. 
The development of the HDQoL-C is poorly 
described. Claims that “The HDQOL-C fails to provide 
an explicit definition for its target variables” (p. 320) 
and “content validity was not informed by carers, but 
by QoL and HD experts” (p. 320) are inaccurate. The 
HDQoL- C is grounded in psychometric theory and 
was developed based on the WHO definition of Qual-
ity of life. Carers were considered experts of their own 
experience and were involved throughout the develop-
ment of the HDQOL-C [1,3,4]. This misunderstanding 
by H&S appears to contribute to their dismissal of the 
need for a HD-specific measure. 
The HDQoL-C gives carers a way of quantifying their 
experience of living with HD and has been beneficial 
within clinical practice, on an individual level and in 
HD carer research (e.g. 5). We argue that a generic scale 
could not identify disease-specific issues which in turn, 
could significantly impact on tailored support for this 
unique group. Moreover, H&S’s preferred scale is 
behind a pay wall with no peer reviewed validation 
paper available in the public domain. The HDQoL- 
C and its psychometric properties are freely available 
for families, clinicians and researchers to access and 
use for the benefit of improving the quality of life of 
families living with HD (http://www.nottingham. 
ac.uk/nmpresearch/hdqol-c/documents.aspx). 
We welcome robust and objective psychometric 
evaluation of our scale and have an increasing dataset 
that researchers who have requested permission to use  
the scale, have kindly shared with us. We have extended 
this invitation to H&S, and would be happy to include 
their data within a more robust analysis of the HDQOL-
C in a larger cohort of participants. 
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